Related Experiment Video

Updated: May 12, 2026

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Antecedent glycemic control reduces severe hypoglycemia-induced neuronal damage in diabetic rats

Candace M Reno1, Tariq Tanoli, Adam Bree

  • 1Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine;

American Journal of Physiology. Endocrinology and Metabolism
|April 18, 2013
PubMed

Insights

Good blood glucose control in diabetic rats protected their brains from severe hypoglycemia. This finding suggests that managing blood sugar levels may prevent brain damage in people with diabetes.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Diabetology

Background:

  • Severe hypoglycemia can cause brain damage in individuals with diabetes treated with insulin.
  • Elevated blood glucose levels in diabetes may exacerbate this damage.

Purpose of the Study:

  • To test if chronic insulin therapy normalizing blood glucose in diabetic rats offers neuroprotection against severe hypoglycemia.
  • To investigate the impact of antecedent glycemic control on hypoglycemia-induced brain injury.

Main Methods:

  • Male Sprague-Dawley rats were divided into control, diabetic (STZ-induced), and insulin-treated diabetic groups.
  • Chronic insulin therapy was administered for 3 weeks to normalize blood glucose in one diabetic group.
  • Rats underwent acute severe hypoglycemic clamps (10-15 mg/dl) for 1 hour, followed by analysis of brain damage and cognitive function.

Main Results:

  • Severe hypoglycemia caused significantly more neuronal damage in diabetic rats compared to control rats (15-fold increase).
  • Chronic insulin treatment in diabetic rats, which normalized glucose levels, substantially reduced hypoglycemia-induced neuronal damage.
  • No cognitive deficits were observed in any group following the hypoglycemic episodes.

Conclusions:

  • Antecedent blood glucose control is a critical factor in neuroprotection against severe hypoglycemia in diabetic subjects.
  • Modifiable therapeutic interventions focused on glycemic control can mitigate brain damage associated with severe hypoglycemia in diabetes.
  • This study highlights the importance of tight glycemic management for preventing neurological complications in diabetes.
Keywords:
brain damagediabetessevere hypoglycemia

More Related Videos

Retinal Pathophysiological Evaluation in a Rat Model09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...